These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38186577)

  • 1. NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer.
    Sun X; Wen H; Li F; Bukhari I; Ren F; Xue X; Zheng P; Mi Y
    Oncol Res; 2023; 32(2):283-296. PubMed ID: 38186577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune infiltration and prognosis in gastric cancer: role of NAD+ metabolism-related markers.
    Xing Y; Zhang Z; Gao W; Song W; Li T
    PeerJ; 2024; 12():e17833. PubMed ID: 39099656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
    Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
    Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nicotinamide adenine dinucleotide (NAD
    Cai L; Ke C; Lin Z; Huang Y; Wang A; Wang S; Chen C; Zhong C; Fu L; Hu P; Chai J; Zhang H; Zhang B
    J Gastrointest Oncol; 2022 Dec; 13(6):2845-2862. PubMed ID: 36636067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
    Liu HY; Wang FH; Liang JM; Xiang YY; Liu SH; Zhang SW; Zhu CM; He YL; Zhang CH
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2743-2756. PubMed ID: 35776198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of prognostic indicator based on NAD+ metabolism related genes in glioma.
    Chen X; Wu W; Wang Y; Zhang B; Zhou H; Xiang J; Li X; Yu H; Bai X; Xie W; Lian M; Wang M; Wang J
    Front Surg; 2023; 10():1071259. PubMed ID: 36778644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
    Tan Z; Fu S; Zuo J; Wang J; Wang H
    Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NAD
    Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
    Front Genet; 2022; 13():905238. PubMed ID: 35783253
    [No Abstract]   [Full Text] [Related]  

  • 15. NAD
    Ye B; Pei Y; Wang L; Meng D; Zhang Y; Zou S; Li H; Liu J; Xie Z; Tian C; Jiang Y; Qiao Y; Gao X; Zhang Y; Ma N
    J Cell Biochem; 2024 Mar; 125(3):e30522. PubMed ID: 38224175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer.
    Zhang S; Li S; Guo JL; Li N; Zhang CN; Liu J
    Dis Markers; 2021; 2021():8886897. PubMed ID: 34603561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
    BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
    Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
    J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [m
    Chen S; Dong R; Li Y; Wu H; Liu M
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):681-689. PubMed ID: 35673911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.